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We are facing a world epidemic of type 2 diabetes that
is now one of the biggest threats to the health of the
world for the 21
st Century. Previously published figures
by the IDF are already gross underestimates of the cur-
rent situation as recent studies from China suggest a
prevalence of diabetes of almost 10%: thus the combined
population of diabetic individuals from China and India
is likely > 150 million individuals. In Australasia,
diabetes prevalence is increasing, particularly amongst
the native population. Diabetic foot problems have been
recognised as increasingly important in recent years as
they represent the commonest cause of hospital admis-
sion amongst diabetic patients in Western countries, are
responsible for much morbidity and even mortality and
are a major economic drain on the health care system.
Data from the USA suggests > $30 billion is spent by
the health care system on diabetic foot ulceration and
amputation each year. In order to prevent foot ulcers
there is a need to have a uniformly agreed screening
programme that can be applied worldwide wherever the
patient is screened, at home, in primary or secondary
care. There is data to suggest that those patients with a
history of previous neuropathic plantar ulcers who were
randomised to self-monitor skin temperatures, were
advised that if a differenceo fm o r et h a n1 . 5 ° Cw a s
found consistently between the two feet, they should
rest: in that group compared to standard therapy, there
was a highly significant reduction of recurrent ulcers
from approximately 30% to 8% annual risk. There is
also increasing evidence that the implementation of a
multi-disciplinary foot care team across not only sec-
ondary but also primary care might help reduce the rate
of amputations in people with diabetes. With respect to
therapy, different modes of offloading remain the key to
achieving appropriate healing in neuropathic ulcers. For
complex diabetic foot wounds, negative pressure wound
therapy using vacuum-assisted closure has supportive
evidence from 2 randomised controlled trials in the area
of wound healing. Most recently, hyperbaric oxygen
therapy (HBO) whose efficacy has previously been ques-
tioned, has received support for improving wound heal-
ing in patients with ischaemic foot ulcers in whom
vascular reconstruction is not possible. A well designed
study from Sweden has confirmed the benefit of HBO
and also suggests that this may result in few amputa-
tions and better quality of life. Other new areas such as
gene therapy and other topical treatments are still await-
ing confirmation of efficacy from properly designed ran-
domised controlled trials rather than anecdotal case
series.
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